etoposide has been researched along with sodium salicylate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cook, JM; Florence, AT; Russell, J; Wheldon, TE | 1 |
| Bau, JT; Kurz, EU | 1 |
2 other study(ies) available for etoposide and sodium salicylate
| Article | Year |
|---|---|
Etoposide (VP-16) uptake by tumour spheroids and activity in the presence of Brij 30, formulation additives and sodium salicylate.
Topics: Adjuvants, Pharmaceutic; Animals; Etoposide; Mice; Mitosis; Neuroblastoma; Polidocanol; Polyethylene Glycols; Sodium Salicylate; Surface-Active Agents; Tumor Cells, Cultured | 1989 |
Sodium salicylate is a novel catalytic inhibitor of human DNA topoisomerase II alpha.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antigens, Neoplasm; Catalysis; Cell Line, Tumor; DNA Damage; DNA Topoisomerases, Type II; DNA-Binding Proteins; Doxorubicin; Enzyme Inhibitors; Etoposide; Free Radical Scavengers; Humans; Phosphorylation; Protein Serine-Threonine Kinases; Signal Transduction; Sodium Salicylate; Transcription, Genetic | 2011 |